Pixurvi Moves Closer to Market in France

Pixurvi Moves Closer to Market in France

There are 1 comment on the Lymphoma Info story from Aug 20, 2013, titled Pixurvi Moves Closer to Market in France. In it, Lymphoma Info reports that:

Cell Therapeutics is reporting that the Transparency Commission of the French National Health Authority has granted market access to CTI for its oncology product Pixurvi as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.

Join the discussion below, or Read more at Lymphoma Info.

Anonymous

France

#1 Aug 21, 2013
hey you out there good quality steroids
at good price and without prescription.burn it it out..
contact at [email protected] for details and quotes tganks

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
Benign tumor Mar 17 Bharath k 1
News Myriad Genetics Announces an Assay that Identif... Feb '17 Purplemouse2 8
News Holzer receives donation from Fruth pharmacies Jan '17 Steve 1
News New team players: Palliative care specialists f... Jan '17 Death 3
News Should Gerard Depardieu Have Worn Adult Diapers... (Aug '11) Jan '17 kirton 2
News Endothelial SCUBE2 Interacts With VEGFR2 and Re... Jan '17 TW_sugar_daddio 3
News Few Care for the Undocumented With Breast Cancer Dec '16 HOLLA ISABELLA 2
More from around the web